c-fos elimination compensates for disabled-2 requirement in mouse extraembryonic endoderm development

Developmental Dynamics

Volumn 238, Issue 3, 2009, Pages 514-523

  Yang, Dong Hua ^b,c   Smith, Elizabeth R ^a   Cai, Kathy Qi ^b   Xu, Xiang Xi Michael ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

c Fos; Cell positioning organization; Cell surface positioning; Disabled 2 (Dab2); Epithelial polarity; MAPK; Mouse embryos; Primitive endoderm

Indexed keywords

DISABLED 2 PROTEIN; PHOSPHOPROTEIN; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO MEMBRANE; ENDODERM; GENE DELETION; KNOCKOUT MOUSE; LETHALITY; MOUSE; NONHUMAN; ONCOGENE C FOS; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL DIFFERENTIATION; DOWN-REGULATION; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; ENDODERM; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-FOS; STEM CELLS;

MUS;

EID: 61649097724     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21856     Document Type: Article

References (38)

1. Bonifacino JS, Traub LM. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72:395-447.
2. Curran T, Franza BR Jr. 1988. Fos and Jun: the AP-1 connection. Cell 55:395-397.
3. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX. 1999. Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene 18:3104-3113.
4. Gertler FB, Bennett RL, Clark MJ, Hoffmann FM. 1989. Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58:103-113.
5. Hasson T. 2003. Myosin VI: two distinct roles in endocytosis. J Cell Sci 116:3453-3461.
6. He J, Smith ER, Xu XX. 2001. Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation. J Biol Chem 276:26814 -26818.
7. Howell BW, Gertler FB, Cooper JA. 1997a. Mouse disabled (mDab1): a Src binding protein implicated in neuronal development. EMBO J 16:121-132.
8. Howell BW, Hawkes R, Soriano P, Cooper JA. 1997b. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389:733-737.
9. Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM. 1994. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J 13:3094-3103.
10. Huang CL, Cheng JC, Liao CH, Stern A, Hsieh JT, Wang CH, Hsu HL, Tseng CP. 2004. Disabled-2 is a negative regulator of integrin alpha(IIb)beta(3)- mediated fibrinogen adhesion and cell signaling. J Biol Chem 279:42279-42289.
11. Inoue A, Sato O, Homma K, Ikebe M. 2002. DOC-2/DAB2 is the binding partner of myosin VI. Biochem Biophys Res Commun 292:300-307.
12. Johnson RS, Spiegelman BM, Papaioannou V. 1992. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577-586.
13. Kumar JP, Hsiung F, Powers MA, Moses K. 2003. Nuclear translocation of activated MAP kinase is developmentally regulated in the developing Drosophila eye. Development 130:3703-3714.
14. Marenda DR, Vrailas AD, Rodrígues AB, Cook SE, Powers MA, Lorenzen JA, Perkins LA, Moses K. 2006. MAP kinase subcellular localization controls both pattern and proliferation in the developing Drosophila wing. Development 133:43-51.
15. Mishra SK, Keyel PA, Hawryluk MJ, Agostinelli NR, Watkins SC, Traub LM. 2002. Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J 21:4915-4926.
16. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS. 1998. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 16:2381-2387.
17. Montell DJ. 2005. Anchors away! Fos fosters anchor-cell invasion. Cell 121:816-817.
18. Morris SM, Cooper JA. 2001. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2:111-123. Erratum in: Traffic 2002 3:236.
19. Morris SM, Arden SD, Roberts RC, Kendrick-Jones J, Cooper JA, Luzio JP, Buss F. 2002a. Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton. Traffic 3:331-341.
20. Morris SM, Tallquist MD, Rock CO, Cooper JA. 2002b. Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport. EMBO J 21:1555-1564.
21. Oleinikov AV, Zhao J, Makker SP. 2000. Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Biochem J 3:613-621.
22. Reichmann E, Schwarz H, Deiner EM, Leitner I, Eilers M, Berger J, Busslinger M, Beug H. 1992. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71:1103-1116.
23. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM. 1995. c-fos is required for malignant progression of skin tumors. Cell 82:721-732.
24. Sheldon M, Rice DS, D'Arcangelo G, Yoneshima H, Nakajima K, Mikoshiba K, Howell BW, Cooper JA, Goldowitz D, Curran T. 1997. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 389:730-733.
25. Sheng Z, Sun W, Smith ER, Cohen C, Sheng Z, Xu XX. 2000. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells. Oncogene 19:4847-4854.
26. Sherwood DR, Butler JA, Kramer JM, Sternberg PW. 2005. FOS-1 promotes basement-membrane removal during anchor-cell invasion in C. elegans. Cell 121:951-962.
27. Smith ER, Capo-chichi CD, He J, Smedberg JL, Yang DH, Prowse AH, Godwin AK, Hamilton TC, Xu XX. 2001a. Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells. J Biol Chem 276:47303-47310.
28. Smith ER, Smedberg JL, Rula ME, Hamilton TC, Xu XX. 2001b. Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiation. J Biol Chem 276:32094-32100.
29. Smith ER, Smedberg JL, Rula ME, Xu XX. 2004. Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells. J Cell Biol 164:689-699.
30. Tallquist MD, Soriano P. 2000. Epiblast-restricted cre expression in MORE mice: a tool to distinguish embryonic vs. extraembryonic gene function. Genesis 26:113-115.
31. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J. 1999. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97:689-701.
32. Vrailas AD, Marenda DR, Cook SE, Powers MA, Lorenzen JA, Perkins LA, Moses K. 2006. smoothened and thickveins regulate Moleskin/Importin 7-mediated MAP kinase signaling in the developing Drosophila eye. Development 133:1485-1494.
33. Wang SC, Makino K, Xia W, Kim JS, Im SA, Peng H, Mok SC, Singletary SE, Hung MC. 2001. DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene 20:6960-6964.
34. Xu XX, Yang W, Jackowski S, Rock CO. 1995. Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product. J Biol Chem 270:14184-14191.
35. Yang DH, Smith ER, Cohen C, Patriotis C, Godwin AK, Hamilton TC, Xu XX. 2002a. Molecular events associated with dysplastic morphological transformation and initiation of ovarian tumorigenicity. Cancer 94:2380-2392.
36. Yang DH, Smith ER, Roland IH, Sheng Z, He J, Martin WD, Hamilton TC, Lambeth JD, Xu XX. 2002b. Disabled-2 is essential for endodermal cell positioning and structure formation during early extraembryonic development. Dev Biol 251:27-44.
37. Yang DH, Cai KQ, Roland IH, Smith ER, Xu XX. 2007. Disabled-2 is an epithelial surface positioning gene. J Biol Chem 282:13114-13122.
38. Zhao R, Watt AJ, Battle MA, Li J, Bondow BJ, Duncan SA. 2008. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol 317:614-419.